Vicore takes major step towards a clinical platform company targeting AT2R - new molecule ready for phase 1

Corporate Breaking News

Home : Vicore takes major step towards a clinical platform company targeting AT2R - new molecule ready for phase 1

Feb 23 2022	Vicore takes major step towards a clinical platform company targeting AT2R - new molecule ready for phase 1
GOTHENBURG, Sweden, Feb. 23, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), today announces advancing its first new chemical entity from the VP03 program to...


Source:https://www.prnewswire.com:443/news-releases/vicore-takes-major-step-towards-a-clinical-platform-company-targeting-at2r--new-molecule-ready-for-phase-1-301488279.html

Related News
» Zevrix Solutions Updates LinkOptimizer for InDesign To Support Creative Cloud 2022 » Seegene underskriver aftale om at levere 4 millioner COVID-19-tests til Brasilien